Back
SELLAS Life Sciences Group Vs. NICE Industry Stock Comparison
Sell
47
SLS
SELLAS Life Sciences Group
Last Price:
1.49
Seasonality Move:
-24.92%
Sell
39
NICE
NICE
Last Price:
167.82
Seasonality Move:
5.24%
Sell
47
SELLAS Life Sciences Group (SLS)
is a Sell
Is SELLAS Life Sciences Group a Buy, Sell or Hold?
- The current SELLAS Life Sciences Group [SLS] share price is $1.50. The Score for SLS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- SLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
NICE (NICE)
is a Sell
Is NICE a Buy, Sell or Hold?
- The current NICE [NICE] share price is $167.90. The Score for NICE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- NICE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SLS Stock Price Chart
What is SELLAS Life Sciences Group's stock price today?
-
The SELLAS Life Sciences Group share price today is $1.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SLS is experiencing selling pressure, which indicates risk of future bearish movement.
NICE Stock Price Chart
SLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 60.08 | Buy |
| Chaikin Money Flow: | -2827573 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.38 - 1.46) | Buy |
| Bollinger Bands (100): | (0.88 - 1.48) | Buy |
NICE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -12.29 | Sell |
| Relative Strength Index (14 RSI): | 28.57 | Sell |
| Chaikin Money Flow: | -2595 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (169.96 - 208.64) | Sell |
| Bollinger Bands (100): | (197.81 - 246.89) | Sell |
SLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.45 | Buy |
| 20-day SMA: | 1.43 | Buy |
| 50-day SMA: | 1.41 | Buy |
| 200-day SMA: | 1.14 | Buy |
| 8-day EMA: | 1.45 | Buy |
| 20-day EMA: | 1.43 | Buy |
| 50-day EMA: | 1.36 | Buy |
| 200-day EMA: | 1.31 | Buy |
NICE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 169.96 | Sell |
| 20-day SMA: | 181.56 | Sell |
| 50-day SMA: | 209.26 | Sell |
| 200-day SMA: | 203.09 | Sell |
| 8-day EMA: | 172.23 | Sell |
| 20-day EMA: | 182.66 | Sell |
| 50-day EMA: | 201.52 | Sell |
| 200-day EMA: | 209.39 | Sell |
SELLAS Life Sciences Group Earnings Growth & SLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and an increase next year of $0.13 per share.
NICE Earnings Growth & NICE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.54 per share, an increase next quarter of $0.25 per share, an increase this year of $1.95 per share, and an increase next year of $1.50 per share.
SELLAS Life Sciences Group Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NICE Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||